Innovation vs. Evidence: ISHLT Experts Clash Over the Role of Robotics in Lung Transplantation

NYU Langone's Dr. Chang and Dr. Reichenspurner debate the clinical benefits vs. the high costs of robotic lung transplants. Read the latest 2026 medical update.

By: AXL Media

Published: Apr 27, 2026, 6:53 AM EDT

Source: Information for this report was sourced from the International Society for Heart and Lung Transplantation (ISHLT).

The Case for Robotic Expansion Dr. Stephanie Chang, a Thoracic and Transplant Surgeon at NYU Langone Health, presented a forward-looking case for robotic integration. She argued that the primary advantage of robotic-assisted surgery lies in its ability to minimize physiologic stress. By moving away from traditional, large-access incisions, surgeons can potentially reduce the "trauma" of the transplant itself.

Key benefits highlighted by Dr. Chang include:

Precision and Vision: Enhanced 3D visualization and dexterity within the thoracic cavity.

Patient Recovery: Reductions in post-operative pain, bleeding, and hospital stays.

Candidate Access: The potential for "frail and older" patients—who might not survive the recovery of a traditional thoracotomy—to become viable transplant candidates.

The Argument for Clinical Pragmatism Presenting the counterpoint, Dr. Hermann Reichenspurner, a pioneer in minimally invasive surgery, argued that "new" does not always mean "better." With over 450 heart transplants to his name, Reichenspurner noted that while robotic systems are impressive "tele-manipulators," they have yet to prove superior to established minimally invasive techniques in any randomized controlled trials.